The following cellular and animal studies demonstrated that SRD5A3 and IGF2BP3 knockdown effectively reduced bladder cancer cell proliferation, prevented chemoresistance, and induced cell apoptosis. This evidence concerns the gene IGF2BP3 and urinary bladder cancer.